Photo by averey from unsplash
This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles… Click to show full abstract
This commentary highlights the findings by Tao et al. (Theranostics 2016; 6: 2068-2083) that targeting miR-433 may be a potential therapeutic strategy for myocardial fibrosis and subsequently discusses the obstacles and prospects associated with the application of therapeutic microRNAs in anti-fibrosis treatment.
Keywords:
modulating micrornas;
fibrosis;
targets cardiac;
micrornas novel;
therapeutic targets;
novel therapeutic
Journal Title: Theranostics
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Theranostics
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!